enrasentan has been researched along with D-fructopyranose in 1 studies
| Studies (enrasentan) | Trials (enrasentan) | Recent Studies (post-2010) (enrasentan) | Studies (D-fructopyranose) | Trials (D-fructopyranose) | Recent Studies (post-2010) (D-fructopyranose) |
|---|---|---|---|---|---|
| 32 | 2 | 0 | 18,095 | 1,041 | 5,633 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellini, G; Bernobich, E; Bertola, G; Bonavita, M; Cosenzi, A; Trevisan, R | 1 |
1 other study(ies) available for enrasentan and D-fructopyranose
| Article | Year |
|---|---|
Antihypertensive treatment with enrasentan (SB217242) in an animal model of hypertension and hyperinsulinemia.
Topics: Animals; Blood Pressure; Body Weight; Carboxylic Acids; Collagen; Dietary Carbohydrates; Disease Models, Animal; Endothelin Receptor Antagonists; Fructose; Hyperinsulinism; Hypertension; Indans; Kidney; Male; Myocardium; Rats; Rats, Inbred WKY | 2002 |